Principle Wealth Partners’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-2,455
| Closed | -$204K | – | 326 |
|
|
2022
Q4 | $204K | Buy |
+2,455
| New | +$204K | 0.02% | 302 |
|
|
2022
Q2 | – | Sell |
-2,295
| Closed | -$206K | – | 330 |
|
|
2022
Q1 | $206K | Hold |
2,295
| – | – | 0.02% | 307 |
|
|
2021
Q4 | $257K | Sell |
2,295
-125
| -5% | -$14K | 0.03% | 281 |
|
|
2021
Q3 | $304K | Sell |
2,420
-2
| -0.1% | -$251 | 0.04% | 247 |
|
|
2021
Q2 | $328K | Hold |
2,422
| – | – | 0.04% | 239 |
|
|
2021
Q1 | $329K | Buy |
2,422
+57
| +2% | +$7.74K | 0.04% | 228 |
|
|
2020
Q4 | $333K | Buy |
2,365
+125
| +6% | +$17.6K | 0.04% | 215 |
|
|
2020
Q3 | $250K | Hold |
2,240
| – | – | 0.07% | 132 |
|
|
2020
Q2 | $251K | Buy |
+2,240
| New | +$251K | 0.07% | 128 |
|
|
2020
Q1 | – | Sell |
-2,240
| Closed | -$213K | – | 174 |
|
|
2019
Q4 | $213K | Buy |
+2,240
| New | +$213K | 0.07% | 156 |
|
|
2019
Q3 | – | Sell |
-2,360
| Closed | -$207K | – | 170 |
|
|
2019
Q2 | $207K | Buy |
+2,360
| New | +$207K | 0.11% | 132 |
|